SPARK Biopharma, Inc.

Private

SeoulHealthcare & Life Scienceshttp://sparkbiopharma.com/

Last Round

Private Equity

May 11, 2026

Est. Valuation

$141.75M

Total Funding Raised

$70.23M

Company Overview

SPARK Biopharma, Inc. is a biotechnology company that develops small-molecule therapeutics using phenotypic discovery platforms for the treatment of oncology, chronic inflammation, and immune disorders.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

drug discoverysmall molecule therapeuticsphenotypic screeningtarget identificationbiotechdrug discovery platformchemical biologyoncology researchinflammatory disease researchdrug licensingbiotech partnershipcompound librarydrug developmentpharma R&Dpreclinical development

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

SPARK Biopharma, Inc. Comps

Public and private peers based on sector, stage, and business model.

SPARK Biopharma, Inc. comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

SPARK Biopharma, Inc. Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Private Equity	May 11, 2026
Series C	Apr 4, 2022
Strategic	Nov 25, 2021
Series B	Aug 26, 2019
Series A	Jul 1, 2018

View all Funding Rounds

Key People

Founding team and executive leadership

조동필

CFO

Executive Team

SPARK Biopharma, Inc. Investors

Notable investors and investment history

SPARK Biopharma, Inc. investors
Investor	Rounds
Shinhan Venture Investment	Series C
KB Investment	Series C, Series B
KB Investment	Series C, Series B, Series A
SJG Partners	Private Equity
Timefolio Asset Management	Series C
Company K Partners	Series C, Series B
KTB Ventures	Series B

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Aug 26, 2019
$21M round led by KTB Ventures.

View all signals

SPARK Biopharma, Inc. Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

SPARK Biopharma, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about SPARK Biopharma, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersSeoul

Employee Range11

Year Founded2016

Last FundingMay 11, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.